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Abstract The Sofia Legionella Fluorescence Immunoassay
(F IA ; Qu i d e l ) i s a r e c en t l y i n t r oduc ed r ap i d
immunochromatographic diagnostic test for Legionnaires’
disease using immunofluorescence technology designed to
enhance its sensitivity. The aim of this study was to evaluate
its performance for the detection of urinary antigens for
Legionella pneumophila serogroup 1 in two National Refer-
ence Centers for Legionella. The sensitivity and specificity of
the Sofia Legionella FIA test were determined in concentrated
and nonconcentrated urine samples, before and after boiling,
in comparison with the BinaxNOW® Legionella Urinary An-
tigen Card (UAC; Alere). Compared with BinaxNOW®
Legionella UAC, the sensitivity of the Sofia Legionella test
was slightly higher in nonconcentrated urine samples and was
identical in concentrated urine samples. The specificity of the
Sofia Legionella FIA test was highly reduced by the concen-
tration of urine samples. In nonconcentrated samples, a lack of
specificity was observed in 2.3 % of samples, all of them
resolved by heat treatment. The Sofia Legionella FIA is a
sensitive test for detecting Legionella urinary antigens with
no previous urine concentration. However, all positive sam-
ples have to be re-tested after boiling to reach a high specific-
ity. The reading is automatized on the Sofia analyzer, which
can be connected to laboratory information systems, facilitat-
ing accurate and rapid reporting of results.
Introduction
The accurate diagnosis of Legionella pneumonia is important
for the treatment of patients by health care providers and for
the control of Legionella epidemics by public health officials.
Rapid urinary antigen detection kits such as lateral flow
immunochromatographic assays detecting L. pneumophila
serogroup 1 are the first-line diagnostic tests for Legionnaires’
disease. In Europe, the 80 % of cases were diagnosed using
urinary antigen kits in 2009–2010 [1].
Various immunochromatographic membrane kits requiring
no specialized laboratory equipment are commercially avail-
able. These tests are easy to perform and provide results in a
few minutes, but they have not demonstrated optimal sensi-
tivity [2–4]. Two approaches have been proposed to increase
the sensitivity of the commercialized kits that are available:
additional readings after a longer incubation time [2, 4–8] and
the concentration of urine samples by centrifugation using
filter units. Several studies showed an increase in the sensitiv-
ity of the BinaxNOW® Legionella Urinary Antigen Card
(UAC) by using concentrated urine samples [4, 9–11].
The Sofia Legionella Fluorescence Immunoassay (FIA;
Quidel, San Diego, CA, USA) is a recently introduced rapid
diagnostic test for Legionnaires’ disease (LD) that uses immu-
nofluorescence technology coupled with an automatic reader
to enhance its sensitivity. To date, no study has been published
on the performance of this test compared with the
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BinaxNOW® Legionella UAC (Alere, Jouy-en-Josas,
France), the kit that is most commonly used. The aim of this
study was to evaluate the performance of Sofia Legionella
FIA in comparison with BinaxNOW® Legionella UAC in
concentrated and nonconcentrated urine samples at two Na-
tional Reference Centers for Legionella.
Materials and methods
Clinical specimens
A total of 269 urine samples were tested in the French and
Swiss National Reference Centers (centers 1 and 2 respective-
ly: 199 in center 1 and 70 in center 2), corresponding to 179
prospective samples submitted for Legionella urinary antigen
detection between January and March 2013 (150 in center 1
and 29 in center 2) and 90 repository urine samples collected
from 2009 to 2013 from patients with known LD and stored at
−20 °C (49 in center 1 and 41 in center 2). Previously, urine
samples had been classified as positive based on a
BinaxNOW® Legionella UAC result obtained from concen-
trated urine samples.
A case of LD was defined according to the European Le-
gionnaires’ Disease Surveillance Network (ELDSNet) criteria
[12], i.e., clinical and/or radiological evidence of pneumonia
associated with positive urinary antigens and/or positive cul-
ture or PCR on respiratory samples. In our study, cases were
diagnosed by positive urinary antigens using BinaxNOW®
Legionella UAC on concentrated urine samples. Twenty-five
cases were confirmed by culture on respiratory samples with
Legionella pneumophila serogroup 1 strain and 7 of them
were Mab3/1-negative.
Legionella urinary antigen detection
The BinaxNOW® Legionella UAC is a colorimetric
immunochromatographic test. A sample was considered pos-
itive when both the control line and the test line were visible
after 15 min of incubation at room temperature.
The Sofia Legionella FIA kit employs a lateral-flow
immunofluorescence technique. The signal is only visible
under UV light. The reading is performed after 10 min of
incubation and interpreted using the SOFIATM analyzer,
which automatically scans the test strip, collects and ana-
lyzes the fluorescence data, and then calculates and re-
ports the result in about 1 min.
With the Binax Legionella Urinary Antigen EIA kit
(Alere), a sample was considered positive when the mean
absorbance value was three times the mean value of the neg-
ative control.
Method
The tests were performed according to the manufacturers’
instructions. In addition, some samples were concentrated
and heat-treated before testing. Urine samples yielding dis-
crepant results before and after heat treatment were checked
by using the Binax Legionella Urinary Antigen EIA kit.
Nonconcentrated urine samples were tested using Sofia
Legionella FIA and the results were compared with those of
nonconcentrated (centers 1 and 2) and those of concentrated
urine samples (center 1 only) tested simultaneously using
BinaxNOW® AUC.
Urinary concentration was performed in center 1 by centri-
fugation at 4,000 g for 10 min using Amikon Ultra-4 Ultracel-
10 k (Millipore Corporation, Bedford, MS, USA) [13].
In the two centers, urine samples yielding a positive result
were retested after heating at 100 °C for 5 min and centrifuga-
tion for 15 min at 1,000 g to exclude false-positive results [14].
Any sample yielding a positive result after heating was
considered true-positive. Any urine sample positive be-
fore heating and negative after heating was considered
false-positive.
Results
Of the 269 nonconcentrated urine samples tested, the Sofia
Legionella FIA test and the BinaxNOW® Legionella UAC
yielded 172 and 181 negative results and 97 and 88 positive
results respectively (Table 1). Of the 9 discrepant samples
yielding a positive result with the Sofia Legionella FIA test,
but a negative one with the BinaxNOW® Legionella UAC, 5
urine samples (4 in center 1 and 1 in center 2) yielded a
negative result with the Sofia Legionella FIA test after
heating. Four of them with a sufficient amount to be checked
with the BinaxNOW® EIA showed a confirmed negative re-
sult. No respiratory samples were available for these 5 pa-
tients. The 4 other urine samples (2 in center 1 and 2 in center
2) remained positive with the Sofia Legionella FIA test after
heating and yielded a positive result with the BinaxNOW®
EIA before and after heating. For 2 of these patients, a
Legionella PCR performed on respiratory samples was posi-
tive and in addition, for one of them a L. pneumophila
serogroup 1-PCR was also positive. For the other one, the
L. pneumophila serogroup 1-PCR was negative.
As several studies demonstrated that urine sample concen-
tration increased the sensitivity of urinary tests, the results of
the BinaxNOW® LegionellaUAC on concentrated urine sam-
ples were compared with those of the Sofia Legionella FIA on
nonconcentrated urine samples in center 1 (n=199; Table 2).
The two reagents detected 49 positive samples, confirming the
presence of Legionella urinary antigen. Among them, 2 sam-
ples had not been detected by the BinaxNOW® Legionella
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UAC before concentration. Four discrepant results were ob-
served, yielding a positive result with the Sofia Legionella
FIA and a negative one with the BinaxNOW® Legionella
UAC. These samples were confirmed as negative by the Sofia
Legionella FIA after heating, corresponding to false-positive
results as previously described in Table 1.
Although the manufacturer of the Sofia Legionella FIA does
not recommend urine concentration, we evaluated its impact on
199 concentrated urine samples in center 1. Eleven urine sam-
ples were detected as being positive with use of the Sofia
Legionella FIA, but negative with use of the BinaxNOW®
Legionella UAC. Among these samples, 9 turned out to have
negative results after heating, confirming false positivity. In 1
case there was not enough of the urine sample available for
retesting after heating; thus, it was classified as invalid. The
last sample remained positive after heating, but was detected
as being negative by the BinaxNOW® EIA. Legionella spp.
and L. pneumophila PCR performed on respiratory samples
were negative for this patient.
Discussion
In this work, we evaluated the Sofia Legionella FIA, a recently
introduced rapid diagnostic test for the detection of
L. pneumophila serogroup 1 urinary antigens, which uses im-
munofluorescence technology to enhance its sensitivity.
Although the manufacturers do not recommend urine con-
centration, the centrifugal ultrafiltration method for rapid
concentration of L. pneumophila urinary antigen was evaluat-
ed. The Legionella urinary antigen is stable at 100 °C for
30 min [15]; therefore, all positive samples were retested as
described previously after boiling to suppress nonspecific re-
actions and confirm positive results [9, 14, 16, 17].
Our results demonstrate that the Sofia Legionella FIA test
exhibits higher sensitivity than the BinaxNOW® Legionella
UAC, since it allowed the detection of all the LD-positive
patients with nonconcentrated urine samples. This study also
confirms that the sensitivity of BinaxNOW® LegionellaUAC
is enhanced by the concentration of urine without any de-
crease in specificity. As a matter of fact, 2 nonconcentrated
urine samples that tested negative with the BinaxNOW®
Legionella UAC yielded a positive result after concentration.
Thus, these two tests demonstrated similar performance in
terms of sensitivity only if urine samples are concentrated
for the BinaxNOW® Legionella UAC.
The major limitation of the Sofia Legionella FIA is the
lower specificity compared with the BinaxNOW® Legionella
UAC that was detected in both concentrated and
nonconcentrated urine samples. As a matter of fact, Quidel
recommends us ing the Sof ia Legionel la FIA in
nonconcentrated urine samples. Our results confirm this im-
portant point, since the number of false-positive results in-
creases from 4 before to 11 after concentration. Moreover, 1
out of the 11 false-positive results in concentrated urine sam-
ples remained positive after heating.
These results of sensitivity and specificity were further
confirmed in 214 new prospective urine samples tested
Table 1 Comparison of the
results of the Sofia Legionella
fluorescent immunoassay (FIA)
and the BinaxNOW® Legionella
urinary antigen card (UAC) using
nonconcentrated urine samples
(n=269)
BinaxNOW® Legionella UAC nonconcentrated urine
− + Total





146 26 0 0 172
6a 3a 47 41 97
Total 181 88 269
aOf the 9 discrepant results with nonconcentrated urine samples, 5 (4 in center 1 and 1 in center 2) yielded a
negative result after heating and corresponded to a false-positive diagnosis using the Sofia Legionella FIA test
without heating. The 4 other urine samples (2 in center 1 and 2 in center 2) remained positive after heating and
corresponded to true-positive diagnosis
Table 2 Comparison of the
results of the Sofia Legionella
fluorescent immunoassay (FIA)
using nonconcentrated urine
samples and the BinaxNOW®
Legionella urinary antigen card
(UAC) using concentrated urine
samples in center 1 (n=199)








Total 150 49 199
a These 4 urine samples yielded a negative result after heating and corresponded to the same samples as in the
cells marked a in Table 1 (false-positive results)
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between March and June 2014 in center 1 with Sofia
Legionella FIA performed on nonconcentrated samples and
the BinaxNOW® Legionella UAC on concentrated samples.
Three positive urine samples were equally detected by the two
kits and boiling urine samples eliminated 6 false-positive re-
sults with use of the Sofia Legionella FIA.
Finally, without heat treatment, a lack of specificity was
observed for 2.3 % of all samples tested in this study (11 out
of 483). Because of the consequences of false-positive results
on the patient outcome and on outbreak investigation [17, 18],
the recommendation of boiling any positive urine to differen-
tiate a false-positive result from a true one should be recom-
mended in the manufacturer’s instructions.
The Sofia Legionella FIA may represent a next step in the
evolution of immunoassays, combining lateral flow and fluo-
rescent antibody detection formats. The choice of fluorescent
rather than colorimetric detection is at least partially responsi-
ble for the improved sensitivity demonstrated by the Sofia
Legionella FIA, and this improvement has also been demon-
strated for Influenza virus detection in comparison with sev-
eral colorimetric lateral flow devices [19–22]. Because of its
automated reading rather than subjective readings of the col-
orimetric bands, this assay produces objective data. Moreover,
the Sofia analyzer can be connected to laboratory information
systems to facilitate the accurate and rapid reporting of results.
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